• Publications
  • Influence
Classifying the intensity of pediatric cancer treatment protocols: The intensity of treatment rating scale 2.0 (ITR‐2)
To develop and validate a method of classifying the intensity of pediatric oncology treatments using four operationally defined categories of treatment intensity.
  • 113
  • 16
Feasibility and preliminary outcomes from a pilot study of a brief psychological intervention for families of children newly diagnosed with cancer.
OBJECTIVE To report initial feasibility and outcome from a pilot study of a new three-session intervention for caregivers of children newly diagnosed with cancer, Surviving Cancer CompetentlyExpand
  • 181
  • 12
  • PDF
Conducting a randomized clinical trial of an psychological intervention for parents/caregivers of children with cancer shortly after diagnosis.
OBJECTIVE To report acceptability, feasibility, and outcome data from a randomized clinical trial (RCT) of a brief intervention for caregivers of children newly diagnosed with cancer. METHODExpand
  • 110
  • 12
Evidence-based assessment, intervention and psychosocial care in pediatric oncology: a blueprint for comprehensive services across treatment.
OBJECTIVE This paper describes the translation of psychological research into clinical services in pediatric oncology, based on two decades of research and clinical services in the Division ofExpand
  • 158
  • 7
  • PDF
A revision of the intensity of treatment rating scale: Classifying the intensity of pediatric cancer treatment
We previously developed a reliable and valid method for classifying the intensity of pediatric cancer treatment. The Intensity of Treatment Rating Scale (ITR‐2.0) 1 classifies treatments into fourExpand
  • 91
  • 6
A Qualitative Study of Phase III Cancer Clinical Trial Enrollment Decision-Making: Perspectives from Adolescents, Young Adults, Caregivers, and Providers.
Purpose: The mortality reduction rate for adolescents and young adults (AYAs) with cancer has not demonstrated the same rate of improvement as for children, due partly to insufficient phase IIIExpand
  • 29
  • 4
A Randomized, Double-Blind, Multicenter Study of Caspofungin Versus Liposomal Amphotericin B for Empiric Antifungal Therapy in Pediatric Patients With Persistent Fever and Neutropenia
Background: Persistently febrile neutropenic children at risk for invasive fungal infections receive empiric antifungal therapy as a standard of care. However, little is known about the role ofExpand
  • 123
  • 3
Screening for psychosocial risk in pediatric cancer
Major professional organizations have called for psychosocial risk screening to identify specific psychosocial needs of children with cancer and their families and facilitate the delivery ofExpand
  • 97
  • 3
The diversity of redox proteins involved in bacterial heterotrophic nitrification and aerobic denitrification.
  • 64
  • 3
Screening for Psychosocial Risk at Pediatric Cancer Diagnosis: The Psychosocial Assessment Tool
Background To investigate the feasibility of integrating an evidence-based screening tool of psychosocial risk in pediatric cancer care at diagnosis. Methods Parents of children newly diagnosed withExpand
  • 58
  • 3
  • PDF